Biovascular's Series C Round

Biovascular raised a round of funding on February 22, 2008.

BioVascular Inc. is a privately held biotechnology company that develops drugs and devices for the control of intimal hyperplasia associated with vascular procedures and control of risk factors associ…

Articles about Biovascular's Series C Round: